Macquarie Group LTD Catalent, Inc. Transaction History

Macquarie Group LTD

  • $85.1 Billion
  • Q2 2024

A detailed history of Macquarie Group LTD transactions in Catalent, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 5,665 shares of CTLT stock, worth $340,523. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,665
Previous 148,694 96.19%
Holding current value
$340,523
Previous $8.39 Million 96.21%
% of portfolio
0.0%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
SELL
$53.58 - $57.02 $7.66 Million - $8.16 Million
-143,029 Reduced 96.19%
5,665 $318,000
Q1 2024

May 14, 2024
SELL
$42.56 - $59.82 $2.49 Million - $3.49 Million
-58,415 Reduced 28.2%
148,694 $8.39 Million
Q4 2023

Feb 14, 2024
BUY
$32.18 - $46.57 $253,481 - $366,831
7,877 Added 3.95%
207,109 $9.31 Million
Q3 2023

Nov 14, 2023
BUY
$44.2 - $50.2 $96,223 - $109,285
2,177 Added 1.1%
199,232 $9.07 Million
Q2 2023

Aug 14, 2023
BUY
$31.86 - $67.26 $364,637 - $769,790
11,445 Added 6.17%
197,055 $8.54 Million
Q1 2023

May 15, 2023
SELL
$45.44 - $74.26 $1.59 Million - $2.6 Million
-34,995 Reduced 15.86%
185,610 $12.2 Million
Q4 2022

Feb 21, 2023
SELL
$41.39 - $81.0 $506,034 - $990,306
-12,226 Reduced 5.25%
220,605 $9.93 Million
Q3 2022

Nov 14, 2022
SELL
$72.36 - $113.1 $5.32 Million - $8.31 Million
-73,505 Reduced 23.99%
232,831 $16.8 Million
Q2 2022

Aug 15, 2022
SELL
$87.2 - $114.05 $3.91 Million - $5.12 Million
-44,886 Reduced 12.78%
306,336 $32.9 Million
Q1 2022

May 16, 2022
BUY
$94.19 - $124.49 $6.75 Million - $8.92 Million
71,687 Added 25.65%
351,222 $39 Million
Q4 2021

Feb 11, 2022
BUY
$119.57 - $139.07 $3.68 Million - $4.28 Million
30,747 Added 12.36%
279,535 $35.8 Million
Q3 2021

Nov 12, 2021
BUY
$109.17 - $142.35 $12 Million - $15.7 Million
110,116 Added 79.41%
248,788 $33.1 Million
Q2 2021

Aug 13, 2021
BUY
$100.34 - $115.69 $899,247 - $1.04 Million
8,962 Added 6.91%
138,672 $15 Million
Q1 2021

May 14, 2021
BUY
$101.51 - $125.27 $2.92 Million - $3.61 Million
28,802 Added 28.54%
129,710 $13.7 Million
Q4 2020

Feb 16, 2021
SELL
$85.88 - $105.36 $40.5 Million - $49.7 Million
-472,010 Reduced 82.39%
100,908 $10.5 Million
Q3 2020

Nov 13, 2020
SELL
$72.74 - $92.5 $478,774 - $608,835
-6,582 Reduced 1.14%
572,918 $49.1 Million
Q2 2020

Aug 11, 2020
SELL
$48.02 - $79.04 $18.2 Million - $30 Million
-379,840 Reduced 39.59%
579,500 $42.5 Million
Q1 2020

May 15, 2020
SELL
$36.95 - $62.95 $4.78 Million - $8.14 Million
-129,297 Reduced 11.88%
959,340 $49.8 Million
Q4 2019

Feb 14, 2020
BUY
$47.06 - $56.64 $5.1 Million - $6.14 Million
108,370 Added 11.06%
1,088,637 $61.3 Million
Q3 2019

Nov 14, 2019
SELL
$47.45 - $58.05 $11.5 Million - $14 Million
-241,327 Reduced 19.76%
980,267 $46.7 Million
Q2 2019

Aug 14, 2019
SELL
$39.26 - $54.21 $4.13 Million - $5.7 Million
-105,119 Reduced 7.92%
1,221,594 $66.2 Million
Q1 2019

May 15, 2019
SELL
$29.84 - $43.92 $13.3 Million - $19.6 Million
-447,159 Reduced 25.21%
1,326,713 $53.9 Million
Q4 2018

Feb 15, 2019
SELL
$29.95 - $46.34 $20.3 Million - $31.4 Million
-676,553 Reduced 27.61%
1,773,872 $55.3 Million
Q3 2018

Nov 15, 2018
BUY
$40.12 - $45.55 $4.07 Million - $4.62 Million
101,366 Added 4.32%
2,450,425 $112 Million
Q2 2018

Aug 14, 2018
BUY
$38.72 - $42.52 $18.3 Million - $20.1 Million
472,228 Added 25.16%
2,349,059 $98.4 Million
Q1 2018

May 11, 2018
BUY
$39.4 - $47.39 $4.82 Million - $5.79 Million
122,253 Added 6.97%
1,876,831 $77.1 Million
Q4 2017

Feb 15, 2018
SELL
$37.27 - $43.02 $11.7 Million - $13.5 Million
-314,745 Reduced 15.21%
1,754,578 $72.1 Million
Q3 2017

Nov 08, 2017
BUY
$33.75 - $41.67 $69.8 Million - $86.2 Million
2,069,323
2,069,323 $82.6 Million

Others Institutions Holding CTLT

# of Institutions
489
Shares Held
165M
Call Options Held
364K
Put Options Held
837K
View Full List

About Catalent, Inc.

CTLT Quotes by TradingView
  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email